Skip to main content
. 2016 Sep 22;7(43):70211–70222. doi: 10.18632/oncotarget.12191

Table 3. Univariate and multivariate analyses of overall survival according to clinicopathological parameters and SPARC levels with 1000 bootstraping.

Characteristics No Uni–variant analysis Multi–variant analysis
Patients Events HR 95% CI P–value HR 95% CI P–value Bootstrapping 95% CI
Age (years) 137 71 1.011 0.988–1.034 0.368
Gender 1.124 0.635–1.988 0.689
 Female 34 15
 Male 103 56
Surgery D2 0.508 0.185–1.396 0.189 0.296 0.103–0.852 0.024 0.076–0.847
 Yes 131 67
 No 6 4
Location 0.750 0.516–1.089 0.130
 Fundus & cardia 8 6
 Body 55 31
 Antrum & pylous 74 34
Differentiation 1.047 0.655–1.675 0.847
 Well & moderate 62 33
 Poor & mixed 75 38
Lauren type 1.627 0.998–2.650 0.051
 Intestinal 59 25
 Diffused 78 46
T stage 2.769 1.313–5.837 0.007 3.032 1.394–6.594 0.005 1.608–8.174
 T1–T3 29 8
 T4 108 63
N stage 3.917 1.692–9.067 0.001 3.866 1.664–8.982 0.002 1.865–10.979
 N0 31 6
 N1–N3 106 65
M stage 1.409 0.431–4.609 0.571
 M0 133 68
 M1 4 3
SPARC expression 1.798 1.080–2.995 0.024 1.835 1.093–3.083 0.022 1.179–3.401
 Negative 53 21
 Positive 84 50